nprnews_____ = ||| lubuntu at wor2 1TXN|||Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.


Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

Pharmacy technician Sara Berech prepared a dose of the Johnson & Johnson COVID-19 vaccine in December for a clinical trial that includes Rocky Mountain Regional VA Medical Center in Aurora, Colo.

Michael Ciaglo/Getty Images


hide caption

toggle caption

Michael Ciaglo/Getty Images


Coronavirus Updates


Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19



The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.


Leave a comment

Design a site like this with WordPress.com
Get started